The Global AI Race: Technological Supremacy Or Collaborative Effort
Scottsdale’s Youtech Fuels National Growth with Local Talent Expansion
Youtech Deepens Texas Roots with Dallas-Area Talent Expansion Across Key Local Sectors
LaunchDarkly Introduces New Release Observability, AI Configurations, and Analytics Capabilities to Help Developers Innovate Faster Without the Risk
Best Debt Relief Programs for 2025 to Help You Get Out of Debt in USA
Geographic atrophy is a progressive, irreversible retinal degenerative disease that can lead to blindness, with…
SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
Management to host conference call today at 5:00 pm ET AUSTIN, Texas, July 22, 2021…
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Lehi, Utah, July 22, 2021 (GLOBE NEWSWIRE) — New U Life Corporation, a health supplements…
PRESS RELEASE AB SCIENCE TO PRESENT RESULTS FROM ITS PHASE III AB09004 STUDY IN MILD…
Information concerning the total number of voting rights and shares, provided pursuant to article L….
First-half 2021 revenue Strong recovery across all activities Q2 revenue: €186.8 M (+25.1% at…
Extensive clinical validation in 678 samples from 213 patients with B-cell malignancies Up to 100-fold…
DECLARATION OF THE NUMBER OF SHARES AND VOTING…
RAANANA, Israel, July 22, 2021 (GLOBE NEWSWIRE) — Trigone Pharma Ltd., a privately owned biopharmaceutical…
MELBOURNE, Australia, July 22, 2021 (GLOBE NEWSWIRE) — Gelteq Pty Ltd, a global leader in…
Lorecivivint post-hoc analysis reveals significantly increased likelihood of symptom improvements for knee osteoarthritis compared to…
Daix (France), July 22, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in…
Altadena, CA, July 22, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq:LIXTE) a clinical-stage…
New twice-a-day dosing regimen allows for daily immune system support Company intends to create a…
Collaboration with Beijing Illness Challenge Foundation seeks to empower patients and improve clinical trial experience…
VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — Levitee Labs Inc. (CSE: LVT) (the “Company” or “Levitee”) is pleased…
Brilacidin showed potent inhibition in multiple human cell lines and in different strains of alphaviruses…